BROWSE·page 155 of 1397

Browse EX-10 agreements

16,757 total material contract exhibits.


EX-10.1

LAGO Evergreen Credit

ExecutionVersion

FOURTHAMENDMENTTOLOANANDSECURITYAGREEMENT ANDJOINDER

This FOURTH AMENDMENT AND JOINDER (this “Amendment”) to the Loan and SecurityAgreementreferencedbelowisenteredintoasofSeptember24,2026,byandamongLAGO EVERGREEN SPE, LLC, a Delaware limited liability company, as borrower (the “Borrower”), LAGO EVERGREEN CREDIT (f/k/a LAGO EVERGREEN CREDIT, LLC, a Delaware limited liability company), a Delaware statutory trust, as servicer (the “Servicer”) and as originator (the “Originator”), LAGO ASSET MANAGEMENT, LLC, a Delaware limited liability company, as investmentmanager(the“InvestmentManager”andcollectivelywiththeBorrower,theServicerand the Originator, each individually a “Lago Party” and collectively the “Lago Parties”), KEYBANK NATIONAL ASSOCIATION, as syndication agent (the “Syndication Agent”), as agent for the Lenders (the “Agent”) and as a lender, Axos Bank, as a lender (together with KeyBank National Association,the“ExistingLenders”),andMUFGBank,Ltd.asanewlender(the“NewLender”and togetherwiththeExistingLenders,the“Lenders”).Capitalizedtermsusedbutnototherwisedefined

…

EX-10.1·8-K·CIK 2043759·ACC 0001193125-26-406949·Filed Sep 29, 2026, 14:41 ET

EXHIBIT 10.1

Monroe Capital Asset-Backed Finance Company, LP

AMENDED AND RESTATED OPERATING AGREEMENT

THIS AMENDED AND RESTATED OPERATING AGREEMENT is made as of September 28, 2026, by and between Monroe Capital Asset-Backed Finance Company, LP, a Delaware series limited partnership (the “Partnership”), and MONROE CAPITAL ASSET FINANCE ADVISORS, LLC, a Delaware limited liability company (together with its permitted assignees, the “Operating Manager”).

WHEREAS, the Partnership and the Operating Manager have entered into that certain Operating Agreement, dated as of July 17, 2026 (the “Existing Operating Agreement”);

WHEREAS, the Partnership and the Operating Manager desire to amend and restate the Existing Operating Agreement in its entirety;

…

EX-10.1·8-K·CIK 2125316·ACC 0001104659-26-111819·Filed Sep 29, 2026, 14:04 ET

EX-10.1

AAR CORP

​

AAR CORP.

Fiscal 2027 Short-Term Incentive Plan

1. Purpose.

The purpose of the AAR CORP. 2027 Short-Term Incentive Plan (“STIP”) is to provide an incentive for selected senior executives of AAR CORP. (the “Company”) and its subsidiaries to achieve the Company’s short-term performance goals by providing them with an annual cash incentive payment based on the financial and operating success of the Company. The STIP payment for the fiscal year ending May 31, 2027 (“Fiscal 2027”) will be based on Earnings Per Share and Working Capital Turns.

2. Definitions.
(a) “Board” means the Board of Directors of the Company.

…

EX-10.1·10-Q·CIK 1750·ACC 0001104659-26-111786·Filed Sep 29, 2026, 12:51 ET

EX-10.2

AAR CORP

Fiscal 2027 Form (Ratable Vesting)

AAR CORP.

Restricted Stock Agreement** (“Agreement”)**

Subject to the provisions of the AAR CORP. 2013 Stock Plan as amended and restated July 13, 2020 (reflecting amendments since July 13, 2020) and the Long-Term Incentive Plan for Fiscal 2027 (together, the “Plan”), the terms of which are hereby incorporated by reference, and in consideration of the agreements of the Grantee herein provided, AAR CORP. a Delaware corporation (“Company”), hereby grants to Grantee a restricted stock award (“Award”), effective July 23, 2026 (“Date of Award”), for the number of shares of common stock (“Common Stock”) of the Company, $1.00 par value (“Award Shares”) set forth in the Company’s notification of Award grant letter to the Grantee, and incorporated herein by reference, subject to the forfeiture and nontransferability provisions hereof and the other terms and conditions set forth herein:

…

EX-10.2·10-Q·CIK 1750·ACC 0001104659-26-111786·Filed Sep 29, 2026, 12:51 ET

EX-10.3

AAR CORP

Fiscal 2027 Form (Cliff Vesting)

AAR CORP.

Restricted Stock Agreement** (“Agreement”)**

Subject to the provisions of the AAR CORP. 2013 Stock Plan as amended and restated July 13, 2020 (reflecting amendments since July 13, 2020) and the Long-Term Incentive Plan for Fiscal 2027 (together, the “Plan”), the terms of which are hereby incorporated by reference, and in consideration of the agreements of the Grantee herein provided, AAR CORP. a Delaware corporation (“Company”), hereby grants to Grantee a restricted stock award (“Award”), effective July 23, 2026 (“Date of Award”), for the number of shares of common stock (“Common Stock”) of the Company, $1.00 par value (“Award Shares”) set forth in the Company’s notification of Award grant letter to the Grantee, and incorporated herein by reference, subject to the forfeiture and nontransferability provisions hereof and the other terms and conditions set forth herein:

…

EX-10.3·10-Q·CIK 1750·ACC 0001104659-26-111786·Filed Sep 29, 2026, 12:51 ET

EX-10.4

AAR CORP

​

Exhibit 10.4

Fiscal 2027 Form (Performance)

AAR CORP.

Performance Restricted Stock Agreement** (“Agreement”)**

Subject to the provisions of the AAR CORP. 2013 Stock Plan as amended and restated effective July 13, 2020 (reflecting amendments since July 13, 2020) and the Long-Term Incentive Plan for Fiscal 2027 (together, the “Plan”), the terms of which are hereby incorporated by reference, and in consideration of the agreements of the Grantee herein provided, AAR CORP., a Delaware corporation (“Company”), hereby grants to the Grantee a performance restricted stock award (“Award”), effective July 23, 2026 (“Date of Award”), for the number of shares of common stock (“Common Stock”) of the Company, $1.00 par value (“Award Shares”) set forth in the Company’s notification of Award grant letter to the Grantee and incorporated herein by reference, subject to the forfeiture and nontransferability provisions hereof and the other terms and conditions set forth herein:

…

EX-10.4·10-Q·CIK 1750·ACC 0001104659-26-111786·Filed Sep 29, 2026, 12:51 ET

EX-10.2

BayFirst Financial Corp.

AMENDED AND RESTATED

EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of September 24, 2026, is made by and among BayFirst Financial Corp., a Florida corporation (the “Company”), BayFirst National Bank, a national association and wholly-owned subsidiary of the Company (the “Bank” and collectively, with the Company, the “Employer”), and Scott J. McKim, a resident of Florida (the “Executive”).

The Company and the Bank shall employ the Executive as its Executive Vice President and Chief Financial Officer. The Employer desires to provide for the employment of the Executive in such capacities, which the Employer has determined will reinforce and encourage the dedication of the Executive to the Employer and will promote the best interests of the Bank, the Company, and the Company’s shareholders. The Executive is willing to serve the Employer in such capacities, on the terms and conditions herein provided. Certain capitalized terms used in this Agreement are defined in Section 20 hereof.

…

EX-10.2·8-K·CIK 1649739·ACC 0001649739-26-000114·Filed Sep 29, 2026, 12:17 ET

EX-10.1

BayFirst Financial Corp.

AMENDED AND RESTATED

EMPLOYMENT AGREEMENT

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of September 24, 2026, is made by and among BayFirst Financial Corp., a Florida corporation (the “Company”), BayFirst National Bank, a national association and wholly-owned subsidiary of the Company (the “Bank” and collectively, with the Company, the “Employer”), and Robin L. Oliver, a resident of Florida (the “Executive”).

The Company and the Bank shall employ the Executive as its Executive Vice President and Chief Operating Officer. The Employer desires to provide for the employment of the Executive in such capacities, which the Employer has determined will reinforce and encourage the dedication of the Executive to the Employer and will promote the best interests of the Bank, the Company, and the Company’s shareholders. The Executive is willing to serve the Employer in such capacities, on the terms and conditions herein provided. Certain capitalized terms used in this Agreement are defined in Section 20 hereof.

…

EX-10.1·8-K·CIK 1649739·ACC 0001649739-26-000114·Filed Sep 29, 2026, 12:17 ET

** **

Dated 24 September 2026

** **

** **

Supplemental Agreement

** **


** **

**Between **

** **

TREASURE GLOBAL INC.

**(Registration No. 7908921) **

** **

(“the Company”)

** **

And

** **

MESTIZ TECHNOLOGY SDN BHD

**[Company Registration No. 200901010248 (853264-U)] **

** **

(“the Developer”)

** **

**THIS SUPPLEMENTAL AGREEMENT **(“Supplemental Agreement”) is made on 24 September 2026 (“Effective Date”).

BETWEEN

** **

TREASURE GLOBAL INC (Registration No. 7908921), a company incorporated in the State of Delaware and having an address for service at 276, 5th Avenue, Suite 704 #739, New York, NY 10001 (the “Company”) of the one part;

AND

…

EX-10.1·8-K·CIK 1905956·ACC 0001213900-26-104429·Filed Sep 29, 2026, 11:00 ET

EXHIBIT 10.2

Silexion Therapeutics Corp

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

SERIES [F][G] ORDINARY SHARE PURCHASE WARRANT

SILEXION THERAPEUTICS CORP

…

EX-10.2·8-K·CIK 2022416·ACC 0001178913-26-004645·Filed Sep 29, 2026, 10:31 ET

EXHIBIT 10.3

Silexion Therapeutics Corp

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT

SILEXION THERAPEUTICS CORP

Warrant Shares: _______ Issue Date: September 29, 2026

…

EX-10.3·8-K·CIK 2022416·ACC 0001178913-26-004645·Filed Sep 29, 2026, 10:31 ET

EXHIBIT 10.1

Silexion Therapeutics Corp

Silexion Therapeutics Corp

September 28, 2026     

Holder of Ordinary Share Purchase Warrants

Re: Inducement Offer to Exercise Ordinary Share Purchase Warrants

Dear Holder:

Silexion Therapeutics Corp (the “Company”) is pleased to offer to you (“Holder”, “you” or similar terminology) (i) the opportunity to receive new warrants to purchase ordinary shares of the Company, par value $0.135 per share (the “Ordinary Shares”) and (ii) a reduction in the Exercise Price (as defined in the respective Existing Warrants) of the Ordinary Share purchase warrants issued on August 13, 2026 set forth on Exhibit A hereto (collectively, the “Existing Warrants”) held by you in consideration for exercising by you for cash all of the Existing Warrants, as set forth on the signature page hereto. The issuance of the Ordinary Shares underlying the Existing Warrants (the “Existing Warrant Shares”) has been registered pursuant to the

…

EX-10.1·8-K·CIK 2022416·ACC 0001178913-26-004645·Filed Sep 29, 2026, 10:31 ET